ALX ONCOLOGY HOLDINGS INC·4

Aug 20, 4:02 PM ET

Shantharam Harish 4

4 · ALX ONCOLOGY HOLDINGS INC · Filed Aug 20, 2025

Insider Transaction Report

Form 4
Period: 2025-08-18
Shantharam Harish
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2025-08-18$0.78/sh+75,000$58,40275,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6823 to $0.9234, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4